NLRP3 and systemic lupus erythematosus: For example, studies have shown that ceramides activate the NLRP3 inflammasome, leading to caspase-1 cleavage and subsequent secretion of pro-inflammatory cytokines, a pathway closely linked to SLE pathogenesis [17].